Ухвалено Стратегію розвитку системи охорони здоров’я на період до 2030 року

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…

In the first half of 2023, sales of medicines in Ukraine reached 420.5 million packages and almost UAH 62.5 billion. The rate of decrease in sales has slowed down significantly.…